BioXcel Therapeutics (BTAI) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-8.09
-5.89
-3.7
-1.5

Details

Expected EPS
-1.8575
Actual EPS
-2.45
Surprise EPS
-0.59
Surprise Percent
+31.9%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -2.45 per share for Q3 2025.

0 Comments

Share your thoughts